P44. Activin A is novel circulating biomarker in lung cancer

BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autori: Rozsas, Anita, Hoda, Mir Alireza, Klikovits, Thomas, Schlech, Karin, Laszlo, Viktoria, Grusch, Michael, Berger, Walter, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Format: Artigo
Jezik:Inglês
Izdano: Pioneer Bioscience Publishing Company 2014
Teme:
CELCC 2014 Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items